A.M.A. Archives of Dermatology and Syphilology
Title | A.M.A. Archives of Dermatology and Syphilology PDF eBook |
Author | |
Publisher | |
Pages | 844 |
Release | 1920 |
Genre | Dermatology |
ISBN |
Download A.M.A. Archives of Dermatology and Syphilology Book in PDF, Epub and Kindle
A.M.A. Archives of Dermatology and Syphilology
Title | A.M.A. Archives of Dermatology and Syphilology PDF eBook |
Author | |
Publisher | |
Pages | 940 |
Release | 1954 |
Genre | Dermatology |
ISBN |
Download A.M.A. Archives of Dermatology and Syphilology Book in PDF, Epub and Kindle
A.M.A. Archives of Dermatology
Title | A.M.A. Archives of Dermatology PDF eBook |
Author | |
Publisher | |
Pages | 1042 |
Release | 1957 |
Genre | Dermatology |
ISBN |
Download A.M.A. Archives of Dermatology Book in PDF, Epub and Kindle
Archives of Dermatology and Syphilology
Title | Archives of Dermatology and Syphilology PDF eBook |
Author | |
Publisher | |
Pages | 844 |
Release | 1922 |
Genre | Dermatology |
ISBN |
Download Archives of Dermatology and Syphilology Book in PDF, Epub and Kindle
Fitzpatrick's Dermatology, 9e
Title | Fitzpatrick's Dermatology, 9e PDF eBook |
Author | Sewon Kang |
Publisher | |
Pages | 2272 |
Release | 2019 |
Genre | |
ISBN | 9780071837811 |
Download Fitzpatrick's Dermatology, 9e Book in PDF, Epub and Kindle
Index of NLM Serial Titles
Title | Index of NLM Serial Titles PDF eBook |
Author | National Library of Medicine (U.S.) |
Publisher | |
Pages | 1316 |
Release | 1981 |
Genre | Medicine |
ISBN |
Download Index of NLM Serial Titles Book in PDF, Epub and Kindle
A keyword listing of serial titles currently received by the National Library of Medicine.
Drug Industry Antitrust Act
Title | Drug Industry Antitrust Act PDF eBook |
Author | United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly |
Publisher | |
Pages | 1182 |
Release | 1961 |
Genre | Antitrust law |
ISBN |
Download Drug Industry Antitrust Act Book in PDF, Epub and Kindle
Considers S. 1552 and companion H.R. 6245, the Drug Industry Antitrust Act, to amend the Federal Food, Drug, and Cosmetic Act and Sherman Antitrust Act to establish drug company licensing procedures, to require FDA to certify the effectiveness of all new drugs, to require advertisements sent to physicians to contain FDA warnings on the drug, and to limit drug company rights to exclusive production of patented drugs.